Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_assertion type Assertion NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_head.
- NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_assertion description "[Our results suggest that ETS-1-DN is a promising candidate for antiangiogenic gene therapy in pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_provenance.
- NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_assertion evidence source_evidence_literature NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_provenance.
- NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_assertion SIO_000772 18772901 NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_provenance.
- NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_assertion wasDerivedFrom befree-20140225 NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_provenance.
- NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_assertion wasGeneratedBy ECO_0000203 NP248164.RAUZCcl7j-2JXEB3ByY_P4wOQL_uBPsNq22Lx0MYLLoNY130_provenance.